Abstract
Actinic cheilitis exhibits a potential of malignant transformation in 10–20 % of cases. The objective of this study was to compare the expression of MDM2 and SUMO-1 proteins between actinic cheilitis (AC) and squamous cell carcinoma (SCC) of the lip. The sample consisted of lower lip mucosa specimens obtained from cases with a clinical and histopathological diagnosis of AC (n = 26) and SCC (n = 25) and specimens of labial semi-mucosa (n = 15) without clinical alterations or inflammation. The tissue samples were stained with hematoxylin-eosin and anti-MDM2 and anti-SUMO-1 antibodies. Data were analyzed by the Kruskal–Wallis and Dunn’s tests (5 %). The median expression of MDM2 (kW = 36.8565; df = 3−1 = 2; p = 0.0001) and SUMO-1 (kW = 32.7080; df = 3−1 = 2; p = 0.0001) was similar in cases of AC and SCC of the lip, but differed significantly from that observed for normal labial semi-mucosa. Despite the limitations of the present study, immunohistochemistry demonstrated the overexpression of important proteins (MDM2 and SUMO-1) related to regulatory mechanisms of apoptosis in AC and SCC of the lip, but further studies are needed.
Similar content being viewed by others
References
Ayres S (1923) Chronic actinic cheilitis. JAMA 81:483–486
Barnes L, Eveson JW, Reichart P, Sidransky D (2005) World Health Organization classification of tumours. IARC Press, Lyon
Batista AC, Costa NL, Oton-Leite AF, Mendonça EF, de Alencar RC, Silva TA (2010) Distinctive clinical and microscopic features of squamous cell carcinoma of oral cavity and lip. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109:e74–e79
Berglund L, Björling E, Oksvold P, Fagerberg L, Asplund A, Szigyarto CA et al (2008) A genecentric Human Protein Atlas for expression profiles based on antibodies. Mol Cell Proteomics 7:2019–2027
Bork K, Hoide N, Korting GW, Burgdorf WHC, Young SK (1993) Diseases of the bucal mucosa and the lips. Malignant tumors. WB Saunders, Germany, pp 326–328
Buschmann T, Fuchs SY, Lee CG, Pan ZQ, Ronai Z (2000) SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53. Cell 101:753–762
Carinci F, Lo Muzio L, Piattelli A, Rubini C, Palmieri A, Stabellini G et al (2005) Genetic portrait of mild and severe lingual dysplasia. Oral Oncol 4:365–374
Cataldo E, Doku HC (1981) Solar cheilitis. J Dermatol Surg Oncol 7:989–995
Cavalcante AS, Anbinder AL, Carvalho YR (2008) Actinic cheilitis: clinical and histological features. J Oral Maxillofac Surg 66:498–503
Daujat S, Neel H, Piette J (2001) MDM2: life without p53. Trends Genet 17:459–464
de Freitas Mda C, Ramalho LM, Xavier FC, Moreira AL, Reis SR (2008) p53 and MDM2 protein expression in actinic cheilitis. J Appl Oral Sci 16:414–419
de Oliveira MG, Ramalho LM, Gaião L, Pozza DH, de Mello RA (2012) Retinoblastoma and p53 protein expression in pre-malignant oral lesions and oral squamous cell carcinoma. Mol Med Rep 6:163–166
Dong YB, Yang HL, Elliott MJ, McMasters KM (2003) Increased mdm-2 expression in a p53-independent manner blocks UV-induced cell cycle arrest and apoptosis in human osteosarcoma cells. Tumour Biol 24:130–139
dos Santos JN, de Sousa SO, Nunes FD, Sotto MN, de Araújo VC (2003) Altered cytokeratin expression in actinic cheilitis. J Cutan Pathol 30:237–241
Girod SC, Pfeiffer P, Ries J, Pape HD (1998) Proliferative activity and loss of function of tumour suppressor genes as ‘biomarkers’ in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma. Br J Oral Maxillofac Surg 36:252–260
Katayama A, Ogino T, Bandoh N, Takahara M, Kishibe K, Nonaka S et al (2007) Overexpression of small ubiquitin-related modifier-1 and sumoylated Mdm2 in oral squamous cell carcinoma: possible involvement in tumor proliferation and prognosis. Int J Oncol 31:517–524
Kim KI, Baek SH (2006) SUMOylation code in cancer development and metastasis. Mol Cells 22:247–253
Krunic AL, Garrod DR, Madani S, Buchanan MD, Clark RE (1998) Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin. Br J Cancer 77:1275–1279
Main JH, Pavone M (1994) Actinic cheilitis and carcinoma of the lip. J Can Dent Assoc 60:113–116
Martínez A, Brethauer U, Borlando J, Spencer ML, Rojas IG (2008) Epithelial expression of p53, mdm-2 and p21 in normal lip and actinic cheilitis. Oral Oncol 44:878–883
Meek DW, Knippschild U (2003) Posttranslational modification of MDM2. Mol Cancer Res 1:1017–1026
Melchior F, Hengst L (2000) Mdm2-SUMO1: is bigger better? Nat Cell Biol 2:E161–E163
Momand J, Wu HH, Dasgupta G (2000) MDM2–master regulator of the p53 tumor suppressor protein. Gene 242:15–29
Moore S, Johnson N, Pierce A, Wilson D (1999) The epidemiology of lip cancer: a review of global incidence and aetiology. Oral Dis 5:185–195
Oliveira Alves M, Balducci I, Rodarte Carvalho Y, Cabral L, Nunes F, Almeida J (2013) Evaluation of the expression of p53, MDM2, and SUMO-1 in oral lichen planus. Oral Dis 19:775–780
Ribeiro CF, Souza FH, Jordão JM, Haendchen LC, Mesquita L, Schmitt JV et al (2012) Photodynamic therapy in actinic cheilitis: clinical and anatomopathological evaluation of 19 patients. An Bras Dermatol 87:418–423
Sarasin A (1999) The molecular pathways of ultraviolet-induced carcinogenesis. Mutat Res 428:5–10
Sousa FA, Paradella TC, Carvalho YR, Rosa LE (2009) Immunohistochemical expression of PCNA, p53, bax and bcl-2 in oral lichen planus and epithelial dysplasia. J Oral Sci 51:117–121
Souza LR, Fonseca-Silva T, Pereira CS, Santos EP, Lima LC, Carvalho HA et al (2011) Immunohistochemical analysis of p53, APE1, hMSH2 and ERCC1 proteins in actinic cheilitis and lip squamous cell carcinoma. Histopathology 58(3):352–360
Acknowledgments
To National Council of Technological and Scientific Development, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) for financial support, and CIPAX (Medicina diagnóstica) for positive control tissue sections.
Conflict of interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Oliveira Alves, M.G., da Mota Delgado, A., Balducci, I. et al. Study of MDM2 and SUMO-1 expression in actinic cheilitis and lip cancer. Arch Dermatol Res 306, 837–841 (2014). https://doi.org/10.1007/s00403-014-1500-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-014-1500-8